tm logo
BEYRIZO
Live/Registered
REGISTERED

on 23 May 2023

Last Applicant/ Owned by

Thurgauerstrasse 130

Glattpark-Opfikon

CH

8152

Serial Number

97333961 filed on 28th Mar 2022

Registration Number

7059515 registered on 23rd May 2023

in the Principal Register

Correspondent Address

Karl M. Zielaznicki, Esq.

TROUTMAN PEPPER HAMILTON SANDERS LLP

875 THIRD AVENUE

C/O IP SERVICES NYC

NEW YORK, NY 10022

Filing Basis

1. intent to use

Disclaimer

NO DATA

BEYRIZO

Pharmaceutical products for use in the field of neuroscience, namely, for the treatment of neurological and nervous system diseases and disorders; pharmaceutical preparations for the treatment of seizures associated with Dravet Syndrome and Lennox-Gastaut Syndrome

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical products for use in the field of neuroscience, namely, for the treatment of neurological and nervous system diseases and disorders; pharmaceutical preparations for the treatment of seizures associated with Dravet Syndrome and Lennox-Gastaut Syndrome

Mark Details


Serial Number

No 97333961

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 256532000263

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
23rd May 2023REGISTERED-PRINCIPAL REGISTER
23rd May 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
07th Mar 2023PUBLISHED FOR OPPOSITION
07th Mar 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15th Feb 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31st Jan 2023EXAMINER'S AMENDMENT ENTERED
31st Jan 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
31st Jan 2023APPROVED FOR PUB - PRINCIPAL REGISTER
31st Jan 2023EXAMINERS AMENDMENT -WRITTEN
31st Jan 2023EXAMINERS AMENDMENT E-MAILED